Literature DB >> 29763902

Prognostic Factors of Renal Involvement in Systemic Sclerosis.

Edoardo Rosato1, Antonietta Gigante1, Biagio Barbano1, Maria Ludovica Gasperini1, Rosario Cianci2, Maurizio Muscaritoli1.   

Abstract

BACKGROUND/AIMS: Renal involvement is common in systemic sclerosis (SSc), including asymptomatic reduction of glomerular filtration rate (GFR), increased renal resistance indices, scleroderma renal crisis (SRC) and ANCA-associated vasculitis. The aim was to evaluate type and evolution of renal involvement for a period of five years.
METHODS: 121 SSc patients (100 F, 21 M) with mean age of 54.9 ± 13.8, disease duration of 9 ± 6 years, of which 62 had a diffused form and 59 limited form were enrolled. All patients were screened annually for renal function by laboratory examination, ultrasound and color Doppler ultrasound of renal arteries.
RESULTS: Over the five-year observation period, 6 SRC (3 M, 3 F) occurred, four of which required dialysis. One patient developed ANCA-related proliferative glomerulonephritis and the other one acute tubular necrosis. The remaining 113 patients had a preserved renal function (serum creatinine 0.75 ± 0.24 mg/dl, GFR 93.8 ± 20 ml/min, 24h proteinuria 0.20 ± 0.15 g). Doppler indices of intrarenal arterial stiffness increased with progression of capillaroscopic damage and with presence of digital ulcers. A negative correlation was observed between estimated GFR and pulsatile index (p< 0,05, r=-0.198), resistive index(p< 0,01, r=0.267), S/D ratio (p< 0,01, r=-0.237).
CONCLUSION: In SSc patients, renal function was normal for 4.1 years despite the presence of increased intrarenal arterial stiffness. SRC was observed in 4.9% of SSc patients. In SSc patients, a periodic follow-up based on clinical and laboratory evaluation, colorDoppler ultrasound and, in some cases, renal biopsy is required to evaluate renal involvement.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Color Doppler ultrasound; Intrarenal arterial stiffness; Resistive index; Scleroderma renal crisis; Systemic sclerosis

Mesh:

Year:  2018        PMID: 29763902     DOI: 10.1159/000489740

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  6 in total

1.  Effects of care bundles for patients with pressure ulcers and the impact on self-care efficacy.

Authors:  Xiaodan Mao; Lipeng Zhu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Progression of gastrointestinal symptoms over time in patients with systemic sclerosis.

Authors:  Jamie Bering; W Leroy Griffing; Michael Crowell; Sarah B Umar
Journal:  Rheumatol Int       Date:  2021-02-25       Impact factor: 2.631

3.  Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity.

Authors:  Antonietta Gigante; Chiara Pellicano; Giorgia Leodori; Cecilia Napodano; Lorenzo Vantaggio; Francesca Gulli; Mariapaola Marino; Marcella Visentini; Edoardo Rosato; Umberto Basile
Journal:  Clin Exp Immunol       Date:  2021-06-02       Impact factor: 5.732

4.  Secondary Membranous Nephropathy. A Narrative Review.

Authors:  Gabriella Moroni; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-12-03

5.  ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review.

Authors:  Rui Wu; Jiang Su; Yu-Rong Zou; Jing Zhu
Journal:  Eur J Med Res       Date:  2021-03-31       Impact factor: 2.175

6.  Prognostic Role of Measurement of Renal Resistive Index in Systemic Sclerosis.

Authors:  Shefali Khanna Sharma; Arghya Chattopadhyay; Siddharth Jain; Chitra Raj Sharma; Debashish Mishra; Manish Rathi; Mahesh Prakash; Sanjay Jain
Journal:  Mediterr J Rheumatol       Date:  2021-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.